Form 4: Halliburton Executive Van H. Beckwith Sells 10,000 Shares

Sentiment:

SEC Form 4 Filing


EVP, Secretary, and CLO of Halliburton, Van H. Beckwith, sold 10,000 shares of common stock at $36.75 per share on July 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 18, 2024, Van H. Beckwith, EVP, Secretary, and CLO of Halliburton, sold 10,000 shares of Halliburton common stock.
  • The shares were sold at a price of $36.75 per share.
  • The transaction was executed under a Rule 10b5-1 trading plan adopted on February 7, 2024.
  • Following the transaction, Beckwith directly owns 273,908.49 shares of Halliburton common stock.
  • Beckwith also holds options to buy 54,348 shares of Halliburton common stock at an exercise price of $23.57, which were granted on January 15, 2020, and expire on January 15, 2030.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.

Comparison to Industry Standards

  • Comparing Beckwith's holdings and transactions to those of other executives at Halliburton and similar companies (e.g., Schlumberger, Baker Hughes) could provide context.
  • Analyzing the frequency and size of insider sales across the oilfield services industry can help determine if this transaction is typical.
  • Reviewing executive compensation packages and equity ownership guidelines at peer companies can offer insights into the significance of Beckwith's holdings.

Stakeholder Impact

  • The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
01/15/2020Date of grant for options to buy common stock, expiring on 01/15/2030
02/07/2024Date the Reporting Person adopted the Rule 10b5-1 trading plan
07/18/2024Date of the transaction (sale of common stock)
07/22/2024Date of the signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.